{"database": "openregs", "table": "federal_register", "rows": [["E8-28843", "Advisory Committee on the Medical Uses of Isotopes: Meeting Notice", "Notice", "The U.S. Nuclear Regulatory Commission will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on December 18, 2008, to discuss infiltrations of fluorine-18 and therapeutic radiopharmaceuticals as medical events; and the training and experience requirements for the medical use of NeoVista, Inc.'s Epi-Rad<INF>90</INF> strontium-90 ophthalmic system. A copy of the agenda for the meeting will be available at http:// www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by contacting Ms. Ashley Tull using the information below.", "2008-12-05", 2008, 12, "https://www.federalregister.gov/documents/2008/12/05/E8-28843/advisory-committee-on-the-medical-uses-of-isotopes-meeting-notice", "https://www.govinfo.gov/content/pkg/FR-2008-12-05/pdf/E8-28843.pdf", "Nuclear Regulatory Commission", "383", "The U.S. Nuclear Regulatory Commission will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on December 18, 2008, to discuss infiltrations of fluorine-18 and therapeutic radiopharmaceuticals as medical...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["E8-28843"], "units": {}, "query_ms": 0.3463011234998703, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}